CIK 0001725160
- Non-accelerated filer
- Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 823607803
- Phone
- +1 858-263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 24 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-05 | SUN ANTHONY Y President & CEO | Sale | −37,144 | $43.37 | $1.6M | 1,703,435 |
| 2021-04-05 | SUN ANTHONY Y President & CEO | Sale | −400 | $44.21 | $18K | 1,703,035 |
| 2021-04-05 | SUN ANTHONY Y President & CEO | Sale | −224 | $45.06 | $10K | 1,702,811 |
| 2021-04-05 | Johnson David Michael Director | Sale | −12,897 | $43.50 | $561K | 88,855 |
| 2021-04-01 | Bunker Kevin D. Chief Operating Officer | Sale | −2,436 | $43.09 | $105K | 56,504 |
| 2021-04-01 | Bunker Kevin D. Chief Operating Officer | Sale | −1,674 | $43.88 | $73K | 54,830 |
| 2021-04-01 | Bunker Kevin D. Chief Operating Officer | Sale | −100 | $44.90 | $4K | 54,730 |
| 2021-03-10 | Bunker Kevin D. Chief Operating Officer | Sale | −4,720 | $45.24 | $214K | 58,940 |
| 2021-03-03 | Bunker Kevin D. Chief Operating Officer | Sale | −3,700 | $45.07 | $167K | 63,660 |
| 2021-03-01 | Bunker Kevin D. Chief Operating Officer | Sale | −4,210 | $41.65 | $175K | 67,360 |
| 2021-03-01 | SUN ANTHONY Y President & CEO | Sale | −7,599 | $41.13 | $313K | 1,786,568 |
| 2021-03-01 | SUN ANTHONY Y President & CEO | Sale | −19,195 | $41.92 | $805K | 1,767,373 |
| 2021-03-01 | Gallagher Cam Director | Sale | −10,000 | $41.69 | $417K | 563,942 |
| 2021-03-01 | Epperly Melissa B, Chief Financial Officer | Sale | −3,083 | $41.67 | $128K | 283,430 |
| 2021-02-11 | Epperly Melissa B, Chief Financial Officer | Grant or award | +15,000 | 286,513 | ||
| 2021-02-11 | Epperly Melissa B, Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2021-02-11 | Pinto Alexis Chief Legal Officer | Grant or award | +6,250 | 6,250 | ||
| 2021-02-11 | Pinto Alexis Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +18,750 | 18,750 | ||
| 2021-02-11 | Bunker Kevin D. Chief Operating Officer | Grant or award | +18,750 | 1,044,464 | ||
| 2021-02-11 | Bunker Kevin D. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +56,250 | 56,250 |
Page 25 of 28 · 545 trades